3Scan's platform provides quantitative image analysis of diseases like cancer, Parkinson's, Alzheimer's and Huntington's disease. 3Scan is a San Francisco based company founded in 2011 by Todd Huffman, Megan Klimen, Matthew Goodman and Cody Daniel.
3Scan provides embedding, sectioning, image aquisition, processing and image analysis of tissue samples. 3Scan claims to bring precision and repeatability to pathology.
3Scan uses Knife-Edge Scanning Microscopy (KESM) which uses a diamond knife and nano-positioned motions, their proprietary robotic imaging platform and proprietary optics to produce digital 3D tissue models at micron-scale resolution. KESM is claimed to have 400 times the throughput of traditional microscopy.
3Scan has investement from Lux Capital.
Timeline
People
Adam Goulburn
Investor
Alex Morcos
Investor
Chul Sung
Employee
Cody Daniel
Founder
Dave Warner MD PhD
Advisor
David Mayerich
Advisor
Devan Shah
Employee
Ed Boyden
Advisor
Eric Norlin
Investor
JP Isham
Investor
Katy Pelton
Employee
Lindy Fishburne
Investor
Louise C. Abbott, PhD., DVM
Advisor
Matthew Goodman
Founder
Megan Klimen
Founder
Michael Rivlin
Employee
Mike Sullivan
Attorney
Molly Maloof
Employee
Nada Rastad
Attorney
Pascal Levensohn
Investor
Peter Barth
Investor
Peter Glynn
Advisor
Peter Selfridge
Advisor
Scott Norman
Investor
Simone Syed
Investor